|
RobengatopeDrug - Robengatope The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Rose Bengal Sodium, I-131
Strength -
1mCi/VIAL
Applicant -
BRACCO
New Drug Application (NDA) Number -
016224
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bracco Diagnostics Inc
Robengatope
Naropin 10mg/ml Injectable; Injection
Naropin 2mg/ml Injectable; Injection Naropin 5mg/ml Injectable; Injection Naropin 7.5mg/ml Injectable; Injection Robengatope 0.5mci/vial Injectable; Injection Robengatope 1mci/vial Injectable; Injection Requip Eq 2mg Base Tablet; Oral Requip Eq 3mg Base Tablet; Oral Requip Eq 4mg Base Tablet; Oral Requip Eq 5mg Base Tablet; Oral NewDrugInformation |